A Cell-Based Strategy for Bioactivity Determination of Long-Acting Fc-Fusion Recombinant Human Growth Hormone

The long-acting growth hormone (LAGH) is a promising alternative biopharmaceutical to treat growth hormone (GH) deficiency in children, and it was developed using a variety of technologies by several pharmaceutical companies. Most LAGH preparations, such as Fc fusion protein, are currently undergoin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Wenrong, Yu, Lei, Fan, Wenhong, Shi, Xinchang, Liu, Lan, Li, Yonghong, Qin, Xi, Rao, Chunming, Wang, Junzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479951/
https://www.ncbi.nlm.nih.gov/pubmed/30970583
http://dx.doi.org/10.3390/molecules24071389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479951/
https://www.ncbi.nlm.nih.gov/pubmed/30970583
http://dx.doi.org/10.3390/molecules24071389

Ejemplares similares